Patents by Inventor Jean Didelez

Jean Didelez has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220241205
    Abstract: The invention concerns lyophilized pharmaceutical formulations comprising plasmatic proteins or derivatives thereof, hyaluronic acid or a derivative thereof, and optionally one or more other pharmaceutically active ingredients, such as clonidine or a derivative thereof, wherein the lyophilized pharmaceutical formulations are characterized by a reconstitution time of less than 15 minutes. The invention further relates to methods for preparing these formulations, and their use for treating musculoskeletal diseases such as bone or joint diseases.
    Type: Application
    Filed: May 13, 2020
    Publication date: August 4, 2022
    Inventors: Nadia Stricwant, Jean Didelez
  • Patent number: 6899884
    Abstract: A new mumps vaccine is presented, comprising a homogeneous pure isolate derived from the Jeryl-Lynn strain of mumps virus. In a preferred embodiment of the invention the vaccine produces higher seroconversion and anitbody titres than know commercial vaccines.
    Type: Grant
    Filed: November 3, 2003
    Date of Patent: May 31, 2005
    Assignee: SmithKline Beecham Biologicals, s.a.
    Inventors: Nigel Maurice Harford, Brigitte Desiree Alberte Colau, Jean Didelez
  • Publication number: 20040120969
    Abstract: A new mumps vaccine is presented, comprising a homogeneous pure isolate derived from the Jeryl-Lynn strain of mumps virus. In a preferred embodiment of the invention the vaccine produces higher seroconversion and anitbody titres than know commercial vaccines.
    Type: Application
    Filed: November 3, 2003
    Publication date: June 24, 2004
    Inventors: Nigel Maurice Harford, Brigitte Desiree Alberte Colau, Jean Didelez
  • Patent number: 6656476
    Abstract: A new mumps vaccine is presented, comprising a homogeneous pure isolate derived from the Jeryl-Lynn strain of mumps virus.
    Type: Grant
    Filed: August 7, 2002
    Date of Patent: December 2, 2003
    Assignee: SmithKline Beecham Biologicals (S.A.)
    Inventors: Nigel Maurice Harford, Brigitte Desiree Alberte Colau, Jean Didelez
  • Publication number: 20030095984
    Abstract: A new mumps vaccine is presented, comprising a homogeneous pure isolate derived from the Jeryl-Lynn strain of mumps virus.
    Type: Application
    Filed: August 7, 2002
    Publication date: May 22, 2003
    Applicant: SMITHKLINE BEECHAM BIOLOGICALS (S.A.)
    Inventors: Nigel Maurice Harford, Brigitte Desiree Alberte Colau, Jean Didelez
  • Publication number: 20020018784
    Abstract: A new mumps vaccine is presented, comprising a homogeneous pure isolate derived from the Jeryl-Lynn strain of mumps virus.
    Type: Application
    Filed: December 22, 2000
    Publication date: February 14, 2002
    Applicant: SMITHKLINE BEECHAM BIOLOGICALS (S.A.)
    Inventors: Nigel Maurice Harford, Brigitte Desiree Alberte Colau, Jean Didelez
  • Patent number: 6024962
    Abstract: A new mumps vaccine is presented, comprising a homogeneous pure isolate derived from the Jeryl-Lynn strain of mumps virus. In a preferred embodiment of the invention the vaccine produces higher seroconversion and antibody titres than known commercial vaccines.
    Type: Grant
    Filed: May 13, 1996
    Date of Patent: February 15, 2000
    Assignee: Smithkline Beecham Biologicals (S.A.)
    Inventors: Nigel Maurice Harford, Brigitte Desiree Alberte Colau, Jean Didelez